TrialSignal
Clinical trial intelligence report
"SFB 1052/3 - Mechanismen Der Adipositas, Projekt A1: Veränderung Der Neurobiologischen Grundlagen Von Ess-Entscheidungen Bei Adipositas" Engl. "CRC 1052/3 - Obesity Mechanisms, Project A1: Targeting Neurobehavioral Determinants of Obesity"
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT05353504-Jul 28, 2026
NCT ID
NCT05353504
Status
RECRUITING
Phase
NA
Sponsor
Max Planck Institute for Human Cognitive and Brain Sciences
Executive brief
Investment-Ready Snapshot
"SFB 1052/3
Mechanismen Der Adipositas, Projekt A1: Veränderung Der Neurobiologischen Grundlagen Von Ess-Entscheidungen Bei Adipositas" Engl. "CRC 1052/3
Obesity Mechanisms, Project A1: Targeting Neurobehavioral Determinants of Obesity" is a NA clinical asset sponsored by Max Planck Institute for Human Cognitive and Brain Sciences in Overweight and Obesity. SEO and diligence focus: Inulin, Lifestyle intervention, Placebo, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT05353504
Indication
Overweight and Obesity
Modality
behavioral intervention
Target
Inulin, Lifestyle intervention, Placebo
Intervention
Inulin, Lifestyle intervention, Placebo
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.